I would like to think based on the recent PRs related to the synergistic benefits of QM with blockbuster fda approved drugs, the company is going to make amendments to the existing already registered clinical trial into 3 or 4 seperate Trials or may be have the existing trial sub branch off into 3 or 4 to capture all the synergistic benefits in multiple clinical areas. It remains to be seen how the TSOI approaches this with new vigour and enthusiasm. Just my opinion.